Experts: Much To Do But Opportunities Aplenty In China Reforms
This article was originally published in PharmAsia News
Executive Summary
Leading healthcare policy wonks and academics shed light on China’s newly freed up drug prices and what drug-centered healthcare reform might mean for manufacturers at a recent meeting in Shanghai.